Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb Ischemia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
In this randomized clinical trial (RCT) the investigators are trying to find out whether a low-dose therapy with daily short infusions of urokinase using 10 to 21 doses over a maximum of 30 days is capable of prolonging the survival time without major amputation.
Epistemonikos ID: 18a9d0fb2036f547353d70d54cf5324ebadb93e6
First added on: May 11, 2024